Microbiome Drug Manufacturers, Suppliers & Companies
-
Manufacturerbased in Durham, NORTH CAROLINA (USA)
Symberix, an early-stage spin-out of the University of North Carolina at Chapel Hill, aims to improve human health by pioneering the development of symbiotic drugs that work by controlling bacteria without killing them. Symberix’s scientific ...
Symberix - Microbiome Drugs
A microbiome is a collection of microorganisms (and their DNA) that occupy a particular location. The "human microbiome" is composed of trillions of tiny microbes (mostly bacteria) that thrive in our mouth, on our ...
CONTACT SUPPLIER -
Manufacturerbased in New York, NEW YORK (USA)
NuBiyota is a microbiome therapeutics company focused on the development of novel microbiota-based drugs to restore crucial gut equilibrium. An imbalance in this crucial ecosystem is associated with infections, chronic disease and even neurological ...
-
Manufacturerbased in Ottawa, ONTARIO (CANADA)
MedBiome Inc. was launched in 2018 as the result of technologies developed at the University of Ottawa. MedBiome focuses on the development of Precision Microbiome Therapeutics and Precision Microbiome Nutrition that target the production of ...
RapidAIM - Microbiome Platform to Assess Drug-Microbiome Interactions
The RapidAIM technology allows the rapid screening of compounds against individual human microbiomes and greatly accelerates the discovery of compounds that target the human microbiomes. Our current technology can ...
CONTACT SUPPLIER -
Manufacturerbased in Somerville, MASSACHUSETTS (USA)
Finch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and targeted ...
Finch - Model CP101 - Microbiome Therapeutics for Recurrent C. Difficile Infection (CDI)
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most ...
CONTACT SUPPLIER -
Manufacturerbased in Paris, FRANCE
Enterome is pioneering the discovery and development of novel pharmaceuticals based on its unrivalled understanding of the interaction between the gut microbiome and the immune system – the Microbiome-Immunoinflammation Axis. Enterome is using this ...
Enterome - Model EO2401 - Microbiome-Based Drugs
EO2401 is an innovative, off-the-shelf immunotherapy discovered by ...
CONTACT SUPPLIER -
Manufacturerbased in Jenkintown, PENNSYLVANIA (USA)
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as drugs. A completely new approach to drug ...
Microbiome
SFA Therapeutics, Inc. is a development-stage bio-pharmaceutical startup company focused on a new advancement in the treatment of chronic inflammatory disease – the use of microbiome-derived metabolites as ...
CONTACT SUPPLIER -
Manufacturerbased in Oslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
Bio-Me - Model PMP - Precision Microbiome Profiling Technology
of research, including: Microbiome Disease Research, Microbiome Drug Discovery, Nutrition ...
CONTACT SUPPLIER -
Manufacturerbased in Little Chesterford, UNITED KINGDOM
The microbiome represents a paradigm shift that affects every aspect of biomedicine: our gut bacteria control health, disease and drug response throughout the body, and can themselves be a novel type of medicine. The microbiome therefore has the ...
Microbiotica - Microbiome-Based Biomarkers Drug
Microbiotica accesses high quality large-scale clinical datasets in order to identify microbiome-based biomarkers of drug response, drug side-effects or disease progression. The company has accessed ...
CONTACT SUPPLIER -
Manufacturerbased in Huangpu District, CHINA
Moon (Guangzhou) Biotech Co., Ltd., with the title of National High-tech Enterprise, is an innovative biotechnology company focusing on the development and commercialization of microbial products and solutions. With a dedication to discover, ...
Moon Biotech - Microbiome Therapeutics
From tremendous microbiome resources to precision microbe-based drug. Human microbiome is recognized as the central hub of human health and disease development and harbors tremendous microbe-based ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
Seres Therapeutics is a late-clinical stage biotechnology company with a strong development pipeline and rigorous scientific underpinning, working to revolutionize treatment of a wide range of diseases by modulating the function of the human ...
-
Manufacturerbased in Farmington, CONNECTICUT (USA)
Intus Biosciences’ world-leading cidentifies bacteria and delivers answers about the microbiome with unprecedented detail, accuracy and scale. Its patented, validated Titan-1™ platform combines high-throughput assay and analysis technology and is ...
-
Service providerbased in Aarhus, DENMARK
Biomcare specializes in profiling and analyzing the microbiome within us, on us and in the world around us. Most microbiome communities are complex, consisting of a range of different microorganisms at different quantities. Microbiomes everywhere. ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you